Why the study?
Does mono-therapy with low-molecular-weight heparin improve live birth rates in women with risk pregnancies?
Does mono-therapy with low-molecular-weight heparin improve live birth rates in women with risk pregnancies?
LMWH monotherapy in high-risk pregnancies is associated with a high live birth rate, particularly when started early or between weeks 20 and 25.
No takes yet. Share an insight, caveat, or question.
Radtke et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: